Today: 9 June 2026
Brent crude price jumps again as Hormuz shipping risks deepen; traders eye Washington moves
3 March 2026
2 mins read

Brent crude price jumps again as Hormuz shipping risks deepen; traders eye Washington moves

London, March 3, 2026, 18:31 GMT — Trading after hours.

  • Brent crude pushed higher for a third straight session, with traders factoring in renewed concerns over Middle East supply disruptions.
  • Standard Chartered bumped up its 2026 Brent projection, cautioning there’s asymmetric upside risk should disruptions widen.
  • Tanker insurance, rerouting options, and potential U.S. emergency moves all drew close attention from markets.

Brent crude futures jumped roughly 6% to $82.38 a barrel as of 1749 GMT Tuesday, sticking close to their multi-month highs. Standard Chartered hiked its forecast for Brent in the first quarter to $74 a barrel, up from $62, and boosted its 2026 average projection to $70 from $63.50, after the latest bout of unrest in the Middle East. The bank noted that “the forward curve has strengthened notably,” pointing out the market’s willingness to pay a premium for prompt barrels over later delivery. Reuters

The significance comes into sharp relief as the U.S.-Israel conflict with Iran snarls fuel flows and sends shipping firms and insurers scrambling. About 20% of global oil and liquefied natural gas usually moves through the Strait of Hormuz, a bottleneck that traders can’t seem to ignore.

Producer data is now reflecting real supply losses, moving past just speculation. Iraq has slashed output by close to 1.5 million barrels a day, unable to get crude out. Two Iraqi oil officials warned the cuts might swell to over 3 million bpd in the next few days if the disruption continues.

Brent’s recent rally pushed past Monday’s settle at $77.74, and on Tuesday the contract bounced around, trading anywhere from about $78 up to $85 per barrel, based on exchange-linked pricing data. Swings that wide usually spark extra hedging, and margin calls pile up—hardly a recipe for quiet trading.

Saudi Aramco is shifting some crude shipments to the Red Sea, telling certain customers to take delivery at Yanbu, according to people with knowledge of the situation. “There are logistical trade-offs involved,” said Richard Bronze, co-founder at Energy Aspects, citing limits tied to pipelines and terminals. Reuters

Washington is getting involved on the price front. President Donald Trump was set to consider measures to rein in energy costs—among them, according to two sources, a plan for the U.S. to support tanker insurance in the region. Trump told reporters, “as soon as this ends, those prices are going to drop.” Secretary of State Marco Rubio added: “Starting tomorrow you will see us rolling out those phases.” Reuters

With uncertainty swirling, analysts are mapping out a range of outcomes as the market tacks on a “risk premium”—that’s the extra cost traders are willing to pay to account for what they don’t know. Citi puts Brent in an $80 to $90 band, at least for the next week. Meanwhile, JPMorgan figures exports via Hormuz have dropped to roughly 4 million bpd, way down from the typical 16 million. Wood Mackenzie warns that if tankers can’t get moving again soon, Brent could push past $100. Reuters

The rally’s held up by fears of just how much worse things might get, rather than by the losses already logged in recent weeks. If there’s any solid indication that traffic is picking up again, or that threats to energy infrastructure are fading, the premium could evaporate quickly. On top of that, concerns about demand and a firmer dollar would pile on more pressure.

The official release is next. Traders are watching for results from Trump’s policy review, set for later Tuesday—specifically, any indication about tanker insurance backing or moves involving the Strategic Petroleum Reserve, the U.S.’s emergency crude supply. Then comes Wednesday’s U.S. weekly oil inventory data, the next chance to gauge just how scarce barrels might be.

Stock Market Today

  • Alibaba Stock Falls 18% Amid Heavy AI Investment
    June 9, 2026, 10:38 AM EDT. Alibaba shares have dropped 18% year-to-date, weighed down by the company's aggressive spending on artificial intelligence (AI) initiatives. This investment strategy has raised concerns among investors about its impact on short-term profitability. The stock's decline outpaces broader market trends and highlights the risks tech giants face when prioritizing long-term innovation over immediate earnings. Analysts note the move reflects Alibaba's commitment to staying competitive in the evolving technology landscape despite near-term challenges.

Latest articles

Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
MARA stock jumps premarket as annual filing opens door to selling bitcoin stash
Previous Story

MARA stock jumps premarket as annual filing opens door to selling bitcoin stash

CrowdStrike stock holds steady after upbeat 2027 forecast as Wall Street sizes up ARR
Next Story

CrowdStrike stock holds steady after upbeat 2027 forecast as Wall Street sizes up ARR

Go toTop